Tower Research Capital LLC (Trc) Maxcyte, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Maxcyte, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,391 shares of MXCT stock, worth $16,751. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,391
Previous 13,077
74.07%
Holding current value
$16,751
Previous $51,000
74.51%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MXCT
# of Institutions
125Shares Held
65.6MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$40.5 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$40.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$28.5 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$24.9 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$23.8 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $503M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...